Ignite Creation Date:
2024-05-05 @ 5:28 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00464178
Status:
TERMINATED
Last Update Posted:
2022-07-20
First Post:
2007-04-19
Brief Title:
A Phase II Study of Bevacizumab and Bortezomib in Patients With RelapsedRefractory Multiple Myeloma
Sponsor:
Organization:
Hackensack Meridian Health